Biogen (BIIB) stock
Loading…
Open
$249.05
Previous close
$247.13
Day range
$248.04 – $253.00
52W range
$160.36 – $261.00
7-day change
-1.50%
30-day change
+10.58%
Volume
1.13M
10-day avg: 1.02M
Market cap
$36.89B
P/E
108.05
EPS (TTM)
$2.31
Shares outstanding
147.82M
Biogen technical analysis
Not enough price history to compute technical indicators right now.
About Biogen
Biogen (BIIB) shares are trading at $249.59, up +1.00% today. The company belongs to the Health Care sector and has a market capitalization of $36.89B.
The stock’s 52-week range is $160.36 – $261.00, with a price-to-earnings ratio of 108. It has moved -1.50% over the past week and +10.58% over the past month.
Related markets
AllStock market news
-
I’m in my 40s. Should I accept a lower pension in exchange for naming my husband or child as a beneficiary?MarketWatch.com12 min. ago
-
3 US AI Infrastructure Stocks With Earnings Growth Investors Should WatchYahoo Finance1 hr. ago
-
SKS Technologies Group And 2 Australian Insider Owned Growth StocksYahoo Finance1 hr. ago
-
3 Founder Led Stocks To Own In November 2026Yahoo Finance1 hr. ago
-
After Worst Week Since Covid, Look For These Absolute LosersInvestor's Business Daily2 hr. ago
Frequently asked questions
What is the Biogen stock price today?
Biogen (BIIB) is trading at $249.59, up +1.00% today.
What is Biogen’s market cap?
Biogen has a market capitalization of $36.89B and a P/E ratio of 108.
Is BIIB stock a buy?
Our automated daily technical rating for BIIB is — (RSI —). Support sits at — and resistance at —. This is not investment advice.